Recruiting OBSERVATIONAL NCT06599424
IntraRenal HEmoDynamics to IntegraTE CA-AKI Risk and Monitor NephroprotectiIoN by ImpElla Support.
Sponsor: Charite University, Berlin, Germany
Interventions
Observational
Updated 2 times since 2024 Last updated: Sep 12, 2024 Started: Oct 1, 2023 Primary completion: Oct 31, 2024 Completion: Jun 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Chronic Kidney Diseases and Coronary Artery Disease and is currently actively recruiting participants. Charite University, Berlin, Germany leads this study, which shows 2 recorded versions since 2023 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
2 versions recorded-
Sep 2025 — Present [monthly]
Recruiting
-
Oct 2024 — Sep 2025 [monthly]
Recruiting
First recorded
Oct 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Charite University, Berlin, Germany
- German Heart Center
- Heinrich-Heine University, Duesseldorf
Data source: Heinrich-Heine University, Duesseldorf
For direct contact, visit the study record on ClinicalTrials.gov .